Health Policy Commission

The Massachusetts Health Policy Commission (HPC) is an independent state agency that develops policy to reduce healthcare cost growth and improve the quality of patient care. MHA engages and interacts with HPC staff and commissioners alike to ensure that our members’ perspectives are heard, taken into account and included at all stages of the HPC’s research, assessment and recommendations concerning broad healthcare cost and quality goals.
The Health Policy Commission has weighed in on another hospital/health system merger.
The Health Policy Commission (HPC) last Wednesday announced its SHIFT-Care grant awardees.
The HPC is expected to vote Wednesday on the preliminary Cost & Market Impact Review relating to the BID-Lahey merger.
A conference committee will now attempt to resolve differences between the House bill and legislation from the Senate passed last year.
The State House News last week quoted House Speaker Bob DeLeo as saying he expects a House healthcare cost-control bill on the floor by the end of June.
MHA has informed the HPC about patient safety and cost considerations related to insurance companies’ drug policies.
The Massachusetts Public Health Council last week approved the proposed merger of he Beth Israel Deaconess system, Lahey Health, and other entities.
The Health Policy Commission (HPC) released its annual cost trends report last week.
The proposed statewide ballot question to impose one-size-fits-all ratios on hospitals would threaten the state's cost growth benchmark.
The HPC is hosting a peer-to-peer knowledge sharing session on strategies for using telehealth to support behavioral health integration.
The deal involving Lahey Health, the Beth Israel Deaconess system, and other entities received a favorable report from DPH.
The Health Policy Commission (HPC) last week issued its final review of the proposed merger between Partners HealthCare and Massachusetts Eye and Ear.
The Health Policy Commission (HPC) last Wednesday announced a new grant program for eligible providers to help them reduce avoidable acute care use.
SB1174, HB1181/SB1183, SB1269, HB1136, HB1137, HB1207, HB3250, SB1248, SB1270, HB1175, HB1197, SB1230, HB2441, HB2477, HB3514, SB1212, SB1234 Healthcare Facilities
HB1143 / SB1199 An Act Relative to the Closing of Hospital Essential Services
The Health Policy Commission says it is restructuring its standing subcommittees to better align them with “priority policy outcomes.”
The deal involving Lahey Health, the Beth Israel Deaconess system, and other entities will get a full cost and market impact review from the HPC.
The healthcare “cost-containment and reform” bill that the Massachusetts Senate passed at midnight last Thursday offer some positive steps forward, but also areas of concern.
The healthcare “cost-containment and reform” bill that the Massachusetts Senate passed at midnight last Thursday offer some positive steps forward, but also areas of concern.
The Health Policy Commission’s (HPC’s) preliminary Cost and Market Impact Review (CMIR), on the merger between Partners HealthCare and the Massachusetts Eye and Ear Infirmary, and its Massachusetts Eye and Ear Associates physician organization was re

Resources

Click on the links below for easy access to important information related to state healthcare issues and advocacy.
Visit the Commonwealth of Massachusetts websites below to find information on legislative hearings and other meetings of interest to the healthcare community.
To guide your navigation of the legislative process and assist your advocacy efforts, please visit the following state websites:
MHA has also developed the following documents for your information and benefit:
  • Directory of Government Officials
  • 2016-2017/2017-2018 State Legislative Package